搜索
市场行情
自选
新闻
分析
交易工具
选股器
扫码下载
一键诊股 让投资更聪明
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
登录
免费注册
搜索
免费注册
市场行情
/
股票
/
医药与医学研究
/
生物技术与医疗研究
/
auph
/
财务摘要
Aurinia Pharmaceuticals Inc
AUPH
添加自选
16.400
USD
-0.270
-1.62%
收盘 09-23 16:00(美东)
2.11B
总市值
7.36
市盈率 TTM
Aurinia Pharmaceuticals Inc
16.400
-0.270
-1.62%
概览
新闻分析
财务
股票评分
技术分析
预测
持股情况
股息
公司资料
财务摘要
利润表
资产负债表
现金流量表
公司收入
财报
公司估值
风险评估
概览
新闻分析
财务
股票评分
技术分析
预测
持股情况
股息
公司资料
财务摘要
利润表
资产负债表
现金流量表
公司收入
财报
公司估值
风险评估
AUPH 财务数据
通过专为投资者打造的一站式数据看板,全面查看 Aurinia Pharmaceuticals Inc 的财务状况。平台将复杂的财务报表整理为可自定义的视图,助您更轻松地进行财务分析。您可以查看最新年度财务报告,也可以通过利润表、资产负债表和现金流量表,按季度分析公司表现。借助实时财务指标,持续追踪公司的经营状况和市场表现更加便捷。
关键财务比率
总市值
2.11B
股息TTM
0.00
市盈率 TTM
7.36
每股收益TTM
2.23
营业收入
283.06M
净利润
5.75M
净资产收益率
64.98%
总资产收益率
48.54%
Aurinia Pharmaceuticals Inc 财报日历
最新发布
8月 6, 2026
每股收益 / 预测值
0.29
/0.24
营业收入 / 预测值
83.22M
/79.36M
财务报表摘要
单季报
单季报+年报
单季报
年报
YOY
隐藏空白行
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
财务指标
每股收益
80.31%
0.29
54.45%
0.26
15792.34%
1.60
138.63%
0.24
3064.88%
0.16
325.13%
0.17
105.37%
0.01
206.55%
0.10
106.26%
0.01
59.37%
-0.07
-2.09%
-0.19
--
-0.09
--
-0.08
--
-0.18
--
-0.18
--
-0.58
--
--
--
--
--
--
--
--
营业收入
18.87%
83.22M
24.40%
77.70M
28.81%
77.11M
8.41%
73.47M
22.41%
70.01M
24.18%
62.47M
32.76%
59.87M
24.32%
67.77M
37.83%
57.19M
46.19%
50.30M
58.59%
45.09M
-2.27%
54.52M
47.19%
41.49M
59.12%
34.41M
21.50%
28.43M
280.30%
55.78M
325.85%
28.19M
2265.97%
21.63M
--
23.40M
50475.86%
14.67M
净利润
73.91%
37.41M
47.17%
34.35M
14651.15%
210.79M
119.87%
31.55M
2879.64%
21.51M
317.17%
23.34M
105.32%
1.43M
206.72%
14.35M
106.28%
722.00K
58.98%
-10.75M
-3.18%
-26.88M
-49.59%
-13.45M
67.64%
-11.49M
30.36%
-26.21M
21.84%
-26.05M
82.11%
-8.99M
24.45%
-35.52M
25.31%
-37.63M
--
-33.32M
-19.29%
-50.26M
利润率
46.30%
44.96%
18.30%
44.21%
11351.96%
273.35%
102.82%
42.95%
2334.18%
30.73%
274.89%
37.37%
104.01%
2.39%
185.84%
21.17%
104.56%
1.26%
71.94%
-21.37%
34.94%
-59.60%
--
-24.67%
--
-27.70%
--
-76.16%
--
-91.60%
--
-77.78%
--
--
--
--
--
--
--
--
毛利率
2.55%
92.12%
6.21%
91.63%
-2.35%
88.59%
-2.44%
88.87%
6.41%
89.84%
1.99%
86.27%
3.06%
90.73%
4.01%
91.10%
-12.27%
84.42%
-14.36%
84.59%
-7.53%
88.04%
--
87.58%
--
96.23%
--
98.78%
--
95.21%
--
95.93%
--
--
--
--
--
--
--
--
资产负债率
-49.20%
7.63%
-36.76%
8.94%
-30.53%
9.16%
-7.25%
13.66%
-0.29%
15.01%
-10.10%
14.13%
-19.79%
13.18%
-4.45%
14.72%
-11.55%
15.06%
--
15.72%
--
16.44%
--
15.41%
--
17.02%
--
--
--
--
--
--
--
--
--
--
--
--
--
--
利润表
营业收入
18.87%
83.22M
24.40%
77.70M
28.81%
77.11M
8.41%
73.47M
22.41%
70.01M
24.18%
62.47M
32.76%
59.87M
24.32%
67.77M
37.83%
57.19M
46.19%
50.30M
58.59%
45.09M
-2.27%
54.52M
47.19%
41.49M
59.12%
34.41M
21.50%
28.43M
280.30%
55.78M
325.85%
28.19M
2265.97%
21.63M
--
23.40M
50475.86%
14.67M
营业利润
129.44%
46.34M
77.17%
41.42M
142.94%
33.24M
153.19%
29.75M
4679.82%
20.20M
455.86%
23.38M
146.11%
13.68M
172.24%
11.75M
97.27%
-441.00K
77.79%
-6.57M
-5.60%
-29.67M
-71.21%
-16.26M
55.07%
-16.17M
21.90%
-29.58M
14.08%
-28.10M
81.14%
-9.50M
23.65%
-35.99M
25.05%
-37.88M
--
-32.70M
-19.00%
-50.35M
净利润
73.91%
37.41M
47.17%
34.35M
14651.15%
210.79M
119.87%
31.55M
2879.64%
21.51M
317.17%
23.34M
105.32%
1.43M
206.72%
14.35M
106.28%
722.00K
58.98%
-10.75M
-3.18%
-26.88M
-49.59%
-13.45M
67.64%
-11.49M
30.36%
-26.21M
21.84%
-26.05M
82.11%
-8.99M
24.45%
-35.52M
25.31%
-37.63M
--
-33.32M
-19.29%
-50.26M
资产负债表
流动资产
32.36%
541.32M
18.36%
480.24M
10.16%
491.97M
-0.39%
438.74M
-0.17%
408.97M
1.89%
405.76M
5.13%
446.60M
3.28%
440.46M
-1.50%
409.67M
-6.00%
398.22M
-4.01%
424.80M
-7.23%
426.47M
-8.23%
415.91M
-11.30%
423.65M
-13.79%
442.54M
39.63%
459.70M
29.60%
453.19M
28.31%
477.62M
22.39%
513.32M
-18.78%
329.22M
流动负债总额
27.63%
99.89M
26.53%
86.56M
-4.13%
93.72M
-3.04%
76.22M
1.77%
78.27M
-3.72%
68.41M
26.66%
97.76M
6.39%
78.61M
24.72%
76.90M
68.99%
71.05M
67.41%
77.19M
76.92%
73.89M
78.08%
61.66M
24.26%
42.05M
13.44%
46.11M
11.26%
41.77M
18.12%
34.63M
59.98%
33.84M
27.03%
40.65M
54.43%
37.54M
总资产
57.64%
792.26M
43.41%
724.00M
36.49%
751.59M
-3.97%
527.53M
-4.00%
502.56M
-2.28%
504.85M
0.47%
550.64M
-1.02%
549.36M
-4.62%
523.53M
14.36%
516.63M
16.40%
548.06M
13.66%
555.01M
13.84%
548.90M
-10.88%
451.76M
-13.34%
470.86M
35.61%
488.29M
24.82%
482.15M
21.54%
506.90M
17.19%
543.37M
-20.53%
360.07M
总负债
6.06%
177.40M
1.11%
156.37M
-1.68%
170.26M
0.25%
161.76M
5.25%
167.26M
-1.59%
154.66M
1.80%
173.17M
-1.09%
161.36M
1.47%
158.91M
156.15%
157.16M
160.00%
170.11M
151.49%
163.14M
168.26%
156.61M
4.38%
61.35M
1.79%
65.42M
4.80%
64.87M
8.09%
58.38M
25.46%
58.78M
14.96%
64.28M
41.88%
61.89M
总权益
83.38%
614.86M
62.09%
567.63M
54.00%
581.33M
-5.73%
365.77M
-8.04%
335.30M
-2.58%
350.19M
-0.13%
377.48M
-0.99%
388.00M
-7.05%
364.62M
-7.92%
359.48M
-6.78%
377.95M
-7.45%
391.88M
-7.43%
392.29M
-12.88%
390.41M
-15.37%
405.44M
42.01%
423.43M
27.54%
423.77M
21.04%
448.12M
17.50%
479.09M
-27.17%
298.17M
现金流量表
经营净额
18.82%
52.57M
2404.62%
32.56M
51.65%
45.67M
161.02%
44.45M
179.25%
44.24M
106.99%
1.30M
110.41%
30.11M
228.26%
17.03M
660.62%
15.84M
41.28%
-18.60M
36.96%
14.31M
13.57%
-13.28M
89.86%
-2.83M
32.25%
-31.67M
140.31%
10.45M
61.83%
-15.36M
26.61%
-27.87M
12.69%
-46.75M
--
-25.92M
-41.65%
-40.25M
投资净额
713.64%
81.45M
-158.26%
-18.08M
-193.71%
-36.76M
-30.27%
-13.77M
65.63%
-13.27M
-36.97%
31.03M
726.87%
39.22M
46.34%
-10.57M
-588.69%
-38.62M
98.04%
49.23M
-107.32%
-6.26M
60.77%
-19.70M
-112.29%
-5.61M
146.89%
24.86M
45.00%
-3.02M
-53.08%
-50.22M
2631.80%
45.62M
21.16%
-53.02M
--
-5.49M
77.30%
-32.81M
融资净额
110.83%
4.81M
-8.81%
-53.69M
91.80%
-1.89M
-285.38%
-10.49M
-436.61%
-44.39M
-227.80%
-49.34M
-313.23%
-23.05M
-16.72%
-2.72M
-825.70%
-8.27M
-1018.30%
-15.05M
-910.61%
-5.58M
--
-2.33M
-14.93%
1.14M
304.69%
1.64M
-99.67%
688.00K
-100.00%
0.00
4.77%
1.34M
-91.95%
405.00K
--
205.72M
-95.20%
9.08M
营业收入
业务
报告期:
暂无数据
地区
报告期:
暂无数据
常见问题
Aurinia Pharmaceuticals Inc的总收入是多少?
根据Aurinia Pharmaceuticals Inc的FY2025财报,总收入达到了283.06M(同比变化235.13M)。
Aurinia Pharmaceuticals Inc的流动资产是多少?
根据Aurinia Pharmaceuticals Inc的FY2025财报,流动资产为491.97M(同比变化10.16)。
Aurinia Pharmaceuticals Inc的总资产是多少?
根据Aurinia Pharmaceuticals Inc的FY2025财报,Aurinia Pharmaceuticals Inc的总资产为751.59M(同比变化36.49)。
Aurinia Pharmaceuticals Inc的总负债是多少?
根据Aurinia Pharmaceuticals Inc的FY2025财报,Aurinia Pharmaceuticals Inc的总负债为170.26M(同比变化-1.68)。
Aurinia Pharmaceuticals Inc的总权益是多少?
根据Aurinia Pharmaceuticals Inc的FY2025财报,Aurinia Pharmaceuticals Inc的总权益为581.33M(同比变化54.00)。
Aurinia Pharmaceuticals Inc的净营业收入是多少?
根据Aurinia Pharmaceuticals Inc的FY2025财报,Aurinia Pharmaceuticals Inc的净营业收入为106.56M(同比变化478.54)。
Aurinia Pharmaceuticals Inc的净投资是多少?
根据Aurinia Pharmaceuticals Inc的FY2025财报,Aurinia Pharmaceuticals Inc的净投资为-32.77M(同比变化-183.46)。
Aurinia Pharmaceuticals Inc的净融资是多少?
根据Aurinia Pharmaceuticals Inc的FY2025财报,Aurinia Pharmaceuticals Inc的净融资为-106.11M(同比变化-116.15)。
Aurinia Pharmaceuticals Inc的每股收益(EPS)是多少?
根据Aurinia Pharmaceuticals Inc的FY2025财报,每股收益(EPS)为2.14(同比变化5215.69)。
Aurinia Pharmaceuticals Inc的净利润是多少?
根据Aurinia Pharmaceuticals Inc的FY2025财报,净利润为287.20M(同比变化4893.08)。
Aurinia Pharmaceuticals Inc的净利润率是多少?
根据Aurinia Pharmaceuticals Inc的FY2025财报,净利润率为101.47(同比变化4047.75)。
Aurinia Pharmaceuticals Inc的毛利率是多少?
根据Aurinia Pharmaceuticals Inc的FY2025财报,毛利率为88.46(同比变化0.54)。
Aurinia Pharmaceuticals Inc的债务与资产比率是多少?
根据Aurinia Pharmaceuticals Inc的FY2025财报,债务与资产比率为9.16(同比变化-30.53)。
Aurinia Pharmaceuticals Inc的股东权益回报率(ROE)是多少?
根据Aurinia Pharmaceuticals Inc的FY2025财报,股东权益回报率(ROE)为59.91(同比变化3833.98)。
Aurinia Pharmaceuticals Inc的资产回报率(ROA)是多少?
根据Aurinia Pharmaceuticals Inc的FY2025财报,资产回报率(ROA)为44.11(同比变化4112.72)。
Aurinia Pharmaceuticals Inc的营业利润是多少?
根据Aurinia Pharmaceuticals Inc的FY2025财报,营业利润为106.56M(同比变化478.54)。